Loading...
Use of intravenous tissue plasminogen activator and hospital costs for patients with acute ischaemic stroke aged 18–64 years in the USA
INTRODUCTION: Intravenous tissue plasminogen activator (IV tPA) is a globally recommended treatment for patients with acute ischaemic stroke. We examined IV tPA use among patients aged 18–64 years with a primary diagnosis of acute ischaemic stroke in the USA and inpatient costs per hospitalisation b...
Na minha lista:
| Udgivet i: | Stroke Vasc Neurol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4990217/ https://ncbi.nlm.nih.gov/pubmed/27547449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2015-000002 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|